Cohort Study to Assess Population Impact of Current and Evolving Chronic Viral Hepatitis Treatment

Funding Opportunity Number: RFA-PS-16-002
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
CFDA Number: 93.270
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Closing Date: Mar 15, 2016
Award Ceiling: $500,000
Expected Number of Awards: 1
Creation Date: Jan 13, 2016
Funding Opportunity Description: Chronic hepatitis B and C represent a major health problem for the United States. Approximately 3.2 million Americans are chronically infected with hepatitis C virus and 1.25 million with chronic hepatitis B virus, with an estimated 55,000 hepatitis C virus- related deaths and 2,000-4,000 hepatitis B related deaths each year. Data from longitudinal cohorts of patients with chronic hepatitis B and C virus infection are needed to understand the spectrum of disease, the natural history, and the public health impact of chronic viral hepatitis. The purpose of this cooperative agreement is to understand the effectiveness, cost, benefits, and adverse effects of evolving antiviral therapy for hepatitis B virus infection and hepatitis C virus infection on a population basis.



Please enter your comment!
Please enter your name here